IMCD buys in Indonesia
Distributor IMCD has agreed to acquire Megasetia Agung Kimia, which it said “provides a significant platform for further growth in the life science segments in Indonesia”. This will take place in two tranches, with 70% being bought now and the rest in 2025. Closing is expected in December.
“Indonesia is South East Asia’s largest economy and this acquisition provides excellent growth opportunities to strengthen IMCD’s positioning in the life science segments. In addition, it enables us to enhance our offering to local customers and partners,” said Haiko Zuidhoff, vice-president of IMCD APAC.
Founded in 1995, Megasetia claims to be Indonesia’s leading distributor for speciality ingredients for the pharmaceuticals industry, as well as being active in the personal care, home care, animal health and industrial markets. It employs about 160 people at three laboratories, six offices and six warehouses in Indonesia, where it has 1,000 customers and represents over 50 major ingredients producers. Sales were about €60 million in 2020.